NetworkNewsBreaks

MondayOct 30, 2023 10:42 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, will be attending and participating in BIO-Europe, one of Europe’s premier pharmaceutical industry partnering events. The event is slated for Nov. 6­–8, 2023, in Munich, Germany. According to the announcement, Scinai will showcase both its CDMO services, marketed under the brand Scinai Bioservices, and its in-house nanosized VHH antibody-based therapeutics pipeline. In addition, management will be available to meet with potential partners and clients. Scinai offers a state-of-the-art manufacturing facility for biopharmaceutical…

Continue Reading

FridayOct 27, 2023 2:45 pm

NetworkNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Completes High-Definition Survey over PCH Ionic Clay Target IV Project Area

Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0) today announced that it has completed a high-definition lidar and orthophoto survey across an area of 1,702.50 hectares, which includes the company’s priority Ionic Clay Target IV project area in Goias, Brazil. Metro Cúbico Engenharia LTDA, which is headquartered in São Paulo and made up of a multidisciplinary team of professionals with more than 20 years of experience in various technological areas, was engaged by Appia to complete the survey. “Orthophotos are essential for the efficient management of our drill campaign as they provide high-resolution and accurate visual information with maximum detail,” said…

Continue Reading

FridayOct 27, 2023 11:45 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Secures $5.2M in Private Placement and Preferred Investment Option Offerings

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs. The company today announced that it has closed its offering for the issuance and sale of 3,012,049 pre-funded warrants and preferred investment options to purchase up to an aggregate of 3,012,049 common shares, at a purchase price of $0.83 per pre-funded and associated preferred investment option, in a private placement priced at-the-market under Nasdaq rules. Per a previously announced definitive agreement with respect to certain of its outstanding preferred investment options issued in November 2022 and exercisable for 3,272,733…

Continue Reading

FridayOct 27, 2023 10:59 am

NetworkNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Reports on Publication of Low-Dose Suramin for ASD Research

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company, announced that its groundbreaking research will be published in the “Annals of General Psychiatry,” an internationally recognized scientific psychiatry publication. The research was reported in a manuscript titled “Randomized clinical trial of low-dose suramin intravenous infusions for treatment of autism spectrum disorder,” which will be published by the psychiatry publication. Written by PaxMedica chief medical officer Dr. David Hough, MD, along with nine coauthors, the article reports on the potential of monthly suramin intravenous infusions as a safe and potentially efficacious treatment for the core symptoms of autism spectrum disorder (“ASD”). Coauthors of…

Continue Reading

ThursdayOct 26, 2023 4:14 pm

NetworkNewsBreaks – AtomBeam Technologies Inc. Reaches $600K Milestone on StartEngine

AtomBeam, a technology company driving hyper-efficient machine communication, has achieved a significant milestone by reaching the $600,000 mark in its ongoing fundraising campaign hosted on the StartEngine investment platform. According to the announcement, AtomBeam’s capital raising campaign has seen one of the strongest openings on StartEngine recently, rapidly gaining the attention and support of investors. AtomBeam’s compaction software redefines data management through its near real-time reduction of machine-generated files and has resonated strongly with backers who recognize its immense potential. Funds raised through this campaign will play a pivotal role in further advancing AtomBeam’s technology and commercialization. “Reaching the $600,000…

Continue Reading

ThursdayOct 26, 2023 3:40 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), QuantumBasel Announce Two-Year Agreement Extension to Fuel Quantum Commercial Adoption

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services as well as the world’s first commercial supplier of quantum computers, has extended its relationship with QuantumBasel. In addition, according to the announcement, D-Wave is planning to open a European office on the QuantumBasel campus to support the companies’ collaboration in fast tracking the commercialization of quantum computing in the region and facilitating increased development of near-term quantum applications for businesses, governments and researchers. QuantumBasel is Switzerland’s first quantum hub for commercial use embedded in the uptownBasel innovation campus, which serves as a global hub for Industry…

Continue Reading

ThursdayOct 26, 2023 2:43 pm

NetworkNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Expands Leadership Team, Eyes Bright Future

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in the development and support of digital assets and SEC-registered security tokens, previously announced the release of its new company mark and logo, as well as a significant transition in leadership by welcoming Brian J. Esposito as its new chief executive officer. As a renowned entrepreneur and business leader, Esposito brings to the company a proven track record of driving growth and innovation. “It is with great pleasure to announce that after 7 years my search for the right CEO to take this company forward has finally ended. It…

Continue Reading

ThursdayOct 26, 2023 2:38 pm

NetworkNewsBreaks – Astra Energy Inc. (ASRE), HES and SETI to Exhibit at Fort Lauderdale International Boat Show

Astra Energy (OTCQB: ASRE), an innovative clean and renewable energy solution provider, together with Holcomb Energy Systems LLC (“HES”) and Sustainable Energy Technologies, Inc. (“SETI”), is exhibiting at the Fort Lauderdale International Boat Show (“FLIBS”) today through Oct. 29, 2023. Sponsored by Camper and Moretti Yacht Group, FLIBS 2023 is the world’s largest boat show, promoting luxury, innovation, sustainable initiatives, and cutting-edge designs. The event provides an optimal setting to unveil the HES In-Line Power Generator (“ILPG”) and the SETI Power Pack, breakthrough technologies that will cut fuel consumption and harmful emissions — a “sea-change” in power use for the…

Continue Reading

ThursdayOct 26, 2023 2:31 pm

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Clearing Path to Submit NDA for PAX-101

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company, today announced the completion of a type-B meeting with the FDA. During the live meeting, the company discussed positive results of the recent data from its PAX-HAT-301 study of suramin in stage one human African sleeping sickness caused by trypanosoma brucei rhodesiense, a rare and fatal parasitic disease if left untreated. According to the announcement, PaxMedica received constructive feedback that will aid in the completion of the remaining work necessary to file a New Drug Application (“NDA”) expected in the second half of 2024. “This is an important turning point for our young…

Continue Reading

ThursdayOct 26, 2023 1:29 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Request to Continue Listing Is Granted by NASDAQ Hearings Panel

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was notified by the NASDAQ Hearings Panel that its request to continue listing on the NASDAQ capital market has been granted with two conditions. Those conditions call for the company to maintain a closing bid price of $1 per share for 20 consecutive trading sessions on or before Jan. 22, 2024, and hold an annual shareholder meeting on or before March 8, 2024. According to the announcement, the company held a meeting on Aug. 3, 2023, where proposals were approved by shareholders, but shareholders did not have an opportunity to…

Continue Reading